NERVGEN PHARMA CORP. Increase Decrease Through Exercise Of Warrants Equity
NERVGEN PHARMA CORP. (NGEN) reported Increase Decrease Through Exercise Of Warrants Equity of CAD 3.39 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2026-03-31
| Period end | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|
| 2025-12-31 | 3.39M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 139.25K CAD 40-F · filed 2026-03-31 |